NBY News and Press, NovaBay Pharmaceuticals Inc. From 12/02/19

Dry wipes are specifically designed for applying Avenova ® to treat dry eye and blepharitis NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the launch of NovaWipes , a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova ® , on A...

The market is vast with many different options for investors to put money into. You can trade anything from penny stocks to large-cap stocks. When it comes to penny stocks, these are considered to be any equity that trades below $5. The cheap stocks can bring investors large amounts of profits...

NovaBay Pharmaceuticals (NYSEMKT: NBY ) is up  21%  premarket after the launch of NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks...

NovaSight complements Avenova ® Direct for comprehensive internal and external eye health NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaSight ™, a proprietary daily vitamin and mineral supplement specially formulated to support o...

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2019 Results Conference Call November 07, 2019 04:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - President and Chief Executive Officer Jason Raleigh - Chief Financial Officer Conference Call Participants Jef...

NovaBay (NYSEMKT: NBY ): Q3 GAAP EPS of -$0.02 beats by $0.06 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Conference call begins at 4:30 p.m. Eastern time today NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports financial results for the three and nine months ended...

Prescription-strength CelleRx to gently clean skin and ease post-procedure discomfort is now available without a prescription at www.CelleRx.com NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the availability of full-strength CelleRx for consumer purchase with...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that it will report third quarter 2019 financial results after market close on Thursday, November 7, 2019 and will ...

Once-daily system complements Avenova and leverages salesforce calls on eyecare specialists NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces an exclusive 90-...